Group One Trading, L.P. Seagen Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$187.64 - $206.25 $3.8 Million - $4.17 Million	20,240 New	20,240 $3.9 Million
Q4 2022 Feb 09, 2023	BUY	$117.37 - $139.17 $1.45 Million - $1.72 Million	12,358 Added 94.25%	25,470 $3.27 Million
Q3 2022 Nov 09, 2022	SELL	$135.27 - $180.11 $2.58 Million - $3.43 Million	-19,045 Reduced 59.23%	13,112 $1.79 Million
Q2 2022 Aug 11, 2022	BUY	$108.81 - $179.33 $3.5 Million - $5.77 Million	32,157 New	32,157 $5.69 Million
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $931,781 - $1.11 Million	-6,898 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$137.51 - $190.8 $948,543 - $1.32 Million	6,898 New	6,898 $958,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.